Long-Term Extension of Previous rAvPAL-PEG Protocols in Subjects With PKU (PAL-003)
Clinical trial NCT00924703 · COMPLETED
Trial details
- NCT number
- NCT00924703
- Sponsor
- BioMarin Pharmaceutical
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-01-13
- Primary completion
- 2019-01-31
- Enrollment
- 68
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.